Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.69
+0.33 (4.56%)
Aug 14, 2025, 2:14 PM - Market open
Bicycle Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 721.45 | 879.52 | 526.42 | 339.15 | 438.68 | 135.99 | Upgrade
|
| Cash & Short-Term Investments | 721.45 | 879.52 | 526.42 | 339.15 | 438.68 | 135.99 | Upgrade
|
| Cash Growth | -24.95% | 67.07% | 55.22% | -22.69% | 222.58% | 47.63% | Upgrade
|
| Accounts Receivable | - | - | - | 2.05 | 1 | 5.46 | Upgrade
|
| Other Receivables | 60.75 | 35.65 | 24.04 | 19.16 | 10.91 | 9.18 | Upgrade
|
| Receivables | 60.75 | 35.65 | 24.04 | 21.21 | 11.91 | 14.63 | Upgrade
|
| Prepaid Expenses | 22.06 | 13.43 | 11.41 | 9.02 | 7.97 | 5.1 | Upgrade
|
| Total Current Assets | 804.26 | 928.61 | 561.87 | 369.38 | 458.56 | 155.72 | Upgrade
|
| Property, Plant & Equipment | 14.11 | 17.19 | 27.68 | 32.77 | 17.79 | 3.61 | Upgrade
|
| Other Long-Term Assets | 13.81 | 11.07 | 5.79 | 8.46 | 3.45 | 1.82 | Upgrade
|
| Total Assets | 832.18 | 956.87 | 595.34 | 410.61 | 479.79 | 161.15 | Upgrade
|
| Accounts Payable | 18.26 | 15.79 | 13.05 | 6.47 | 2.72 | 1.37 | Upgrade
|
| Accrued Expenses | 38.87 | 35.45 | 26.38 | 21.86 | 11.29 | 10.58 | Upgrade
|
| Current Portion of Leases | 5.43 | 5.5 | 4.88 | 3.13 | 2.38 | 0.84 | Upgrade
|
| Current Unearned Revenue | 14.62 | 10.19 | 24.98 | 20.42 | 19.27 | 10.14 | Upgrade
|
| Other Current Liabilities | 0.24 | 0.3 | 0.26 | 1.47 | 0.57 | 0.21 | Upgrade
|
| Total Current Liabilities | 77.42 | 67.23 | 69.54 | 53.34 | 36.24 | 23.13 | Upgrade
|
| Long-Term Debt | - | - | 30.7 | 30.32 | 29.87 | 14.51 | Upgrade
|
| Long-Term Leases | 1.77 | 3.99 | 9.38 | 10.89 | 12.08 | 0.43 | Upgrade
|
| Long-Term Unearned Revenue | 82.94 | 91.47 | 110.22 | 41.46 | 52.07 | 25.02 | Upgrade
|
| Other Long-Term Liabilities | 1.14 | 1.12 | 4.58 | 3.83 | 3.28 | 2.61 | Upgrade
|
| Total Liabilities | 163.27 | 163.81 | 224.41 | 139.83 | 133.54 | 65.69 | Upgrade
|
| Common Stock | 0.89 | 0.89 | 0.55 | 0.39 | 0.38 | 0.27 | Upgrade
|
| Additional Paid-In Capital | 1,492 | 1,473 | 883.45 | 601.11 | 567.64 | 249.95 | Upgrade
|
| Retained Earnings | -820.5 | -680.79 | -511.76 | -331.1 | -218.38 | -151.56 | Upgrade
|
| Comprehensive Income & Other | -3.36 | 0.12 | -1.3 | 0.39 | -3.39 | -3.19 | Upgrade
|
| Total Common Equity | 668.92 | 793.06 | 370.93 | 270.78 | 346.25 | 95.46 | Upgrade
|
| Shareholders' Equity | 668.92 | 793.06 | 370.93 | 270.78 | 346.25 | 95.46 | Upgrade
|
| Total Liabilities & Equity | 832.18 | 956.87 | 595.34 | 410.61 | 479.79 | 161.15 | Upgrade
|
| Total Debt | 7.2 | 9.49 | 44.96 | 44.33 | 44.34 | 15.78 | Upgrade
|
| Net Cash (Debt) | 714.25 | 870.03 | 481.47 | 294.83 | 394.34 | 120.22 | Upgrade
|
| Net Cash Growth | -22.25% | 80.70% | 63.30% | -25.24% | 228.03% | 33.24% | Upgrade
|
| Net Cash Per Share | 10.32 | 14.95 | 13.53 | 9.94 | 15.73 | 6.28 | Upgrade
|
| Filing Date Shares Outstanding | 69.31 | 69.2 | 42.59 | 30.02 | 29.6 | 23.09 | Upgrade
|
| Total Common Shares Outstanding | 69.25 | 69.06 | 42.43 | 29.87 | 29.58 | 21.09 | Upgrade
|
| Working Capital | 726.84 | 861.38 | 492.33 | 316.04 | 422.32 | 132.59 | Upgrade
|
| Book Value Per Share | 9.66 | 11.48 | 8.74 | 9.06 | 11.71 | 4.53 | Upgrade
|
| Tangible Book Value | 668.92 | 793.06 | 370.93 | 270.78 | 346.25 | 95.46 | Upgrade
|
| Tangible Book Value Per Share | 9.66 | 11.48 | 8.74 | 9.06 | 11.71 | 4.53 | Upgrade
|
| Machinery | 19.4 | 16.53 | 16.91 | 16.24 | 7.11 | 5.97 | Upgrade
|
| Leasehold Improvements | 11.93 | 10.9 | 11 | 10.74 | 0.81 | 0.38 | Upgrade
|
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.